Objective To evaluate the usefulness of the Doppler assessment of left
ventricular diastolic functioning during dipyridamole-induced ischaem
ia in patients with coronary artery disease (CAD). Methods We studied
28 patients with angiographically proven CAD [18 men, aged 62 +/- 7 ye
ars (mean +/- SD)] and 18 normal subjects (12 men, aged 59 +/- 7.5 yea
rs). Two-dimensional and transmitral flow Doppler echocardiography stu
dies were performed at baseline and after intravenous administration o
f a high dose of dipyridamole (0.84 mg/kg during 10 min). Left ventric
ular wall motion was evaluated by two-dimensional Doppler echocardiogr
aphy, with the left ventricle divided into a 16-segment model, whereas
peak velocities of early and late diastolic flow, the early:late dias
tolic flow ratio and the deceleration rate of early diastolic flow wer
e determined from transmitral flow Doppler echocardiography. Results S
ixteen patients developed new wall-motion abnormalities (WMA), whereas
the remaining 12 patients and the controls did not. Multivariate logi
stic regression analysis was performed to identify which of the parame
ters had independent diagnostic value for revealing CAD. WMA was enter
ed at the first step and yielded a 57% sensitivity and 100% specificit
y; the changes in deceleration rate were entered as the second step, w
hich improved the sensitivity to 85.5%, and reduced the specificity to
83% and raised the overall accuracy to 85% from 70% for WMA alone. Mo
re specifically, the sensitivity improved from 37.5, 63.5 and 65.5% to
62.5, 91 and 100%, respectively, for patients with one-, two-and thre
e-vessel disease. The cut-off value of the change in deceleration rate
was 7%. Conclusions Patients could be classified as having CAD either
if they developed new WMA or if the deceleration rate of early diasto
lic flow during dipyridamole-stress echocardiography increased by more
than 7% compared with the rest value. (C) Rapid Science Publishers IS
SN 0954-6928.